Genetic testing for tripler army medical center, hawaii

Ended Blanket Purchase Agreement Awarded Last action

Contract number
W81K0220A0017
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$950,000.00
Maximum order
$250,000.00
Award type
Multiple award
Who can order
Only the awarding agency
NAICS code
621511 Medical Laboratories
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Ambry Genetics Corporation, a subsidiary of Konica Minolta Healthcare Americas, Inc., was awarded a $950,000 Blanket Purchase Agreement (BPA) by the Department of the Army Medical Command on September 8, 2020, with an ultimate completion date of September 7, 2025. The contract was issued under a multiple-award structure with no small business set-aside applied. This BPA was established through a competitive solicitation posted on July 8, 2020, with a due date of August 5, 2020, to support genetic testing services for Tripler Army Medical Center in Hawaii. The contract vehicle enables the military healthcare facility to efficiently order genetic testing services on an as-needed basis throughout the performance period without requiring separate competitive procurements for each order.

Under this agreement, Ambry Genetics Corporation provides specialized genetic testing services, including comprehensive genetic analysis, whole genome sequencing, deletion and duplication analysis, cancer predisposition panels, and variant confirmation services. The contractor's expertise in delivering complex genetic testing solutions supports the Department of Defense's healthcare operations at Tripler Army Medical Center, facilitating diagnostic and research capabilities for military personnel and their families. This contract represents Ambry Genetics Corporation's expansion beyond its primary customer base with the Department of Veterans Affairs, demonstrating the company's capability to serve multiple federal healthcare agencies with advanced genetic reference laboratory testing services.

Quick answers

Who was awarded contract W81K0220A0017?

W81K0220A0017 was awarded to Ambry Genetics Corporation by Medical Command (Department of the Army) on September 8, 2020.

How much is contract W81K0220A0017 worth?

W81K0220A0017's own ceiling is $950,000. A single order can be worth up to $250,000.

Who can order from contract W81K0220A0017?

W81K0220A0017 is a multiple award blanket purchase agreement. Only the awarding agency can place orders on it.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV